Robert Connelly
CEO, President and Director, Director · Elicio Therapeutics, Inc.
Individual
- 2024
- Jul 17, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Robert Connelly's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
- August J. Troendle - $358.45M in MEDP purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Robert M. Williams Jr. - $268.34M in AVAH purchases and sales in the last 12 months
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Connelly?
Robert Connelly is a corporate insider, tracked as CEO, President and Director, Director of Elicio Therapeutics, Inc. (ELTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robert Connelly last file a Form 4?
The most recent primary Form 4 on record is dated 17 July 2026, one of 3 filings going back to 2024.
